MetaVia (MTVA) announced positive results from the 4-week multiple ascending dose Part 2 of its Phase 1 clinical trial of DA-1726, a novel, ...

Pediatric doses associated with consistent exposure across age are still unknown. Therefore, we aim to identify a dosing strategy for ivermectin treatment in both pre-school-aged children (2–5 years ...

“Often, when we are with a patient who is not meeting treatment goals, we need to decide whether to increase a current medication to maximum dose or ... generation glucagon-like peptide 1 ...

The prescribed dosage for Humira (adalimumab) may vary depending on a person’s individual treatment plan. Other factors, including specific diagnosis, body weight, and medical history ...

The prescribed dosage for ondansetron may vary depending on a person’s individual treatment plan. Factors such as your medical history and other medications you take may also affect your dosage ...

No significant safety or dose limiting toxicities have been reported BOSTON, March 27, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more ...

Low dose birth control pills are a type of hormonal birth control that contains lower amounts compared to older forms of contraceptive pills. For some people, low dose birth control pills may ...

A baby boy is critically ill after he was given ten times the correct dose of paracetamol in a hospital. The parents of eight-week-old Zohan Ul Hassan say they are now 'praying for a miracle ...

The Phase 2 VENTURE-Oral Dosing Trial is a randomized, double-blind, placebo-controlled multicenter study designed to evaluate the safety, tolerability, pharmacokinetics and weight loss efficacy ...

In the highest dose group, the average weight of the people who completed ... UBT251 is a long-acting synthetic peptide triple agonist targeting the receptors for GLP-1 (glucagon-like peptide-1), GIP ...

Each Baqsimi device includes 1 dose of glucagon and cannot be refused. The Food and Drug Administration (FDA) has expanded the approval of Baqsimi (glucagon) nasal powder to include the treatment of ...